← Leaderboards
Clay F. Semenkovich
Washington University
$38,041,096
Attributed
$41,513,403
Total exposure
39
Grants
28
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$64,391,107 · 41
By mechanism
P30$20,913,931 · 12
R01$14,765,210 · 10
P50$12,417,016 · 3
T32$12,347,693 · 1
K12$3,500,004 · 1
P60$297,671 · 5
Top collaborators
- Marco Colonna6 shared
- Irfan J Lodhi3 shared
- Maria Sara Remedi1 shared
Most similar at Washington University
Same institution · by research overlap
- Michael A Kass$23,482,010
- Richard E. Ostlund$11,164,127
- Robert E Schmidt$4,976,339
- John W Turk$9,203,839
- Gregory A Ewald$1,047,165
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusMetabolic DiseasesResearch PersonnelWashingtonUniversitiesBaseTissuesPhenotypeFundingAffectObesityProgramsAtherosclerosisResponseMetabolismUnited States National Institutes Of HealthMissionLipid MetabolismAnimalsTrainingMetabolicTranslatingLipidsInnovation
Grant awards (153)
Diabetes Research Center$1,778,982
P30 · FY2025 · DK · contact PI
Diabetes and Related Metabolic Diseases$1,002,952
T32 · FY2025 · DK · contact PI
BCFA Metabolism and the Regulation of Energy Balance$513,150
R01 · FY2025 · DK
Expanded Pilot and Feasability$386,158
P30 · FY2025 · DK · contact PI
Admin Core$295,450
P30 · FY2025 · DK · contact PI
Diabetes Research Center$1,784,028
P30 · FY2024 · DK · contact PI
Diabetes and Related Metabolic Diseases$1,010,582
T32 · FY2024 · DK · contact PI
BCFA Metabolism and the Regulation of Energy Balance$492,625
R01 · FY2024 · DK
Lipidation and Vascular Disease$393,750
R01 · FY2024 · HL · contact PI
Expanded Pilot and Feasability$386,158
P30 · FY2024 · DK · contact PI
Admin Core$295,450
P30 · FY2024 · DK · contact PI
Diabetes Research Center$1,836,330
P30 · FY2023 · DK · contact PI
Diabetes and Related Metabolic Diseases$839,889
T32 · FY2023 · DK · contact PI
BCFA Metabolism and the Regulation of Energy Balance$514,250
R01 · FY2023 · DK
Expanded Pilot and Feasability$428,428
P30 · FY2023 · DK · contact PI
Lipidation and Vascular Disease$393,750
R01 · FY2023 · HL · contact PI
Admin Core$296,401
P30 · FY2023 · DK · contact PI
Diabetes Research Center$1,903,474
P30 · FY2022 · DK · contact PI
Diabetes and Related Metabolic Diseases$773,856
T32 · FY2022 · DK · contact PI
Lipidation and Vascular Disease$393,750
R01 · FY2022 · HL · contact PI
WU P&F$389,484
P30 · FY2022 · DK · contact PI
Diabetes Models Phenotyping$137,251
P30 · FY2022 · DK · contact PI
Diabetes Research Center$1,903,474
P30 · FY2021 · DK · contact PI
Diabetes and Related Metabolic Diseases$772,867
T32 · FY2021 · DK · contact PI
Lipidation and Vascular Disease$393,750
R01 · FY2021 · HL · contact PI
WU P&F$389,484
P30 · FY2021 · DK · contact PI
Diabetes Models Phenotyping$137,251
P30 · FY2021 · DK · contact PI
Diabetes Research Center$1,903,474
P30 · FY2020 · DK · contact PI
Diabetes and Related Metabolic Diseases$690,126
T32 · FY2020 · DK · contact PI
WU P&F$389,484
P30 · FY2020 · DK · contact PI
EPFP - Sub Contracts$378,474
P30 · FY2020 · DK · contact PI
GLUCOCORTICOID RECEPTOR POST-TRANSLATIONAL MODIFICATIONS IN INSULIN RESISTANCE$343,125
R01 · FY2020 · DK · contact PI
Administrative Core$271,603
P30 · FY2020 · DK · contact PI
Animal Model Research Core (AMRC)$148,135
P30 · FY2020 · DK · contact PI
Diabetes Models Phenotyping$137,251
P30 · FY2020 · DK · contact PI
Diabetes Research Center$1,903,474
P30 · FY2019 · DK · contact PI
Diabetes and Related Metabolic Diseases$843,777
T32 · FY2019 · DK · contact PI
WU P&F$389,485
P30 · FY2019 · DK · contact PI
MODULATING PHYSIOLOGIC EFFECTS OF PHOSPHOLIPID METABOLISM IN OBESITY AND DIABETES$377,198
R01 · FY2019 · DK · contact PI
GLUCOCORTICOID RECEPTOR POST-TRANSLATIONAL MODIFICATIONS IN INSULIN RESISTANCE$343,125
R01 · FY2019 · DK · contact PI
Administrative Core$271,600
P30 · FY2019 · DK · contact PI
Animal Model Research Core (AMRC)$148,135
P30 · FY2019 · DK · contact PI
Diabetes and Related Metabolic Diseases$801,752
T32 · FY2018 · DK · contact PI
WU P&F$389,485
P30 · FY2018 · DK · contact PI
MODULATING PHYSIOLOGIC EFFECTS OF PHOSPHOLIPID METABOLISM IN OBESITY AND DIABETES$377,198
R01 · FY2018 · DK · contact PI
Animal Model Research Core (AMRC)$148,135
P30 · FY2018 · DK · contact PI
Diabetes Models Phenotyping$137,250
P30 · FY2018 · DK · contact PI
Diabetes and Related Metabolic Diseases$734,628
T32 · FY2017 · DK · contact PI
MODULATING PHYSIOLOGIC EFFECTS OF PHOSPHOLIPID METABOLISM IN OBESITY AND DIABETES$423,984
R01 · FY2017 · DK · contact PI
Animal Model Research Core (AMRC)$148,135
P30 · FY2017 · DK · contact PI
Diabetes and Related Metabolic Diseases$11,222
T32 · FY2017 · DK · contact PI
Diabetes and Related Metabolic Diseases$743,005
T32 · FY2016 · DK · contact PI
MODULATING PHYSIOLOGIC EFFECTS OF PHOSPHOLIPID METABOLISM IN OBESITY AND DIABETES$426,555
R01 · FY2016 · DK · contact PI
Animal Model Research Core (AMRC)$148,135
P30 · FY2016 · DK · contact PI
Core A: Diabetes Models Phenotyping Core$136,798
P30 · FY2016 · DK · contact PI
Diabetes and Related Metabolic Diseases$707,595
T32 · FY2015 · DK · contact PI
MODULATING PHYSIOLOGIC EFFECTS OF PHOSPHOLIPID METABOLISM IN OBESITY AND DIABETES$423,984
R01 · FY2015 · DK · contact PI
DE NOVO LIPOGENESIS AND METABOLIC DISEASE$330,600
R01 · FY2015 · DK · contact PI
Core A: Diabetes Models Phenotyping Core$146,246
P30 · FY2015 · DK · contact PI
Animal Model Research Core$145,315
P30 · FY2015 · DK · contact PI
Diabetes and Related Metabolic Diseases$436,424
T32 · FY2014 · DK · contact PI
Building Interdisciplinary Careers in Women's Health$400,000
K12 · FY2014 · HD · contact PI
DE NOVO LIPOGENESIS AND METABOLIC DISEASE$330,600
R01 · FY2014 · DK · contact PI
Core A: Diabetes Models Phenotyping Core$146,245
P30 · FY2014 · DK · contact PI
Animal Model Research Core$144,188
P30 · FY2014 · DK · contact PI
Diabetes and Related Metabolic Diseases$419,338
T32 · FY2013 · DK · contact PI
DE NOVO LIPOGENESIS AND METABOLIC DISEASE$319,030
R01 · FY2013 · DK · contact PI
OBESITY, ADIPOGENESIS, AND LIPID LIGANDS$304,585
R01 · FY2013 · DK · contact PI
Animal Model Research Core$154,509
P30 · FY2013 · DK · contact PI
Core A: Diabetes Models Phenotyping Core$129,004
P30 · FY2013 · DK · contact PI
Building Interdisciplinary Careers in Women's Health$100,001
K12 · FY2013 · HD · contact PI
Building Interdisciplinary Careers in Women's Health$500,001
K12 · FY2012 · HD · contact PI
Diabetes and Related Metabolic Diseases$407,616
T32 · FY2012 · DK · contact PI
DE NOVO LIPOGENESIS AND METABOLIC DISEASE$330,600
R01 · FY2012 · DK · contact PI
OBESITY, ADIPOGENESIS, AND LIPID LIGANDS$315,633
R01 · FY2012 · DK · contact PI
Animal Model Research Core$145,314
P30 · FY2012 · DK · contact PI
Diabetes and Related Metabolic Diseases$29,411
T32 · FY2012 · DK · contact PI
Building Interdisciplinary Careers in Women's Health$500,001
K12 · FY2011 · HD · contact PI
Diabetes and Related Metabolic Diseases$387,283
T32 · FY2011 · DK · contact PI
OBESITY, ADIPOGENESIS, AND LIPID LIGANDS$315,633
R01 · FY2011 · DK · contact PI
Animal Model Research Core$145,314
P30 · FY2011 · DK · contact PI
MACROPHAGE FATTY-ACID SYNTHASE DEFICIENCY DECREASES DIET-INDUCED ATHEROSCLEROSIS$4,273
P41 · FY2011 · RR · contact PI
SCCOR in Metabolic Syndrome and Vascular Disease$1,969,905
P50 · FY2010 · HL · contact PI
Building Interdisciplinary Careers in Women's Health$500,001
K12 · FY2010 · HD · contact PI
Genotoxic Stress, Atherosclerosis and Metabolic Syndrome$489,529
P50 · FY2010 · HL · contact PI
Diabetes and Related Metabolic Diseases$456,031
T32 · FY2010 · DK · contact PI
OBESITY, ADIPOGENESIS, AND LIPID LIGANDS$380,000
R01 · FY2010 · DK · contact PI
De Novo Lipogenesis and Metabolic Disease$302,314
R01 · FY2010 · DK · contact PI
SCCOR in Metabolic Syndrome and Vascular Disease$1,969,197
P50 · FY2009 · HL · contact PI
Genotoxic Stress, Atherosclerosis and Metabolic Syndrome$503,311
P50 · FY2009 · HL · contact PI
Interdisciplinary Research Careers in Women's Health$500,000
K12 · FY2009 · HD · contact PI
Diabetes and Related Metabolic Diseases$386,227
T32 · FY2009 · DK · contact PI
De Novo Lipogenesis and Metabolic Disease$305,368
R01 · FY2009 · DK · contact PI
Diabetes and Related Metabolic Diseases$31,510
T32 · FY2009 · DK · contact PI
SCCOR in Metabolic Syndrome and Vascular Disease$1,914,867
P50 · FY2008 · HL · contact PI
Interdisciplinary Research Careers in Women's Health$500,000
K12 · FY2008 · HD · contact PI
Genotoxic Stress, Atherosclerosis and Metabolic Syndrome$497,504
P50 · FY2008 · HL · contact PI
Diabetes and Related Metabolic Diseases$379,792
T32 · FY2008 · DK · contact PI
De Novo Lipogenesis and Metabolic Disease$305,368
R01 · FY2008 · DK · contact PI
Diabetes and Related Metabolic Diseases$31,290
T32 · FY2008 · DK · contact PI
Diabetes and Related Metabolic Diseases$28,050
T32 · FY2008 · DK · contact PI
SCCOR in Metabolic Syndrome and Vascular Disease$1,981,009
P50 · FY2007 · HL · contact PI
Genotoxic Stress, Atherosclerosis and Metabolic Syndrome$504,129
P50 · FY2007 · HL · contact PI
Interdisciplinary Research Careers in Women's Health$500,000
K12 · FY2007 · HD · contact PI
Diabetes and Related Metabolic Diseases$393,311
T32 · FY2007 · DK · contact PI
De Novo Lipogenesis and Metabolic Disease$311,856
R01 · FY2007 · DK · contact PI
Diabetes Research and Training Center$178,943
P60 · FY2007 · DK · contact PI
Diabetes and Related Metabolic Diseases$29,159
T32 · FY2007 · DK · contact PI
INSULIN RESISTANCE AND ATHEROSCLEROSIS$4,632
P41 · FY2007 · RR · contact PI
CHLOROQUINE AND THE METABOLIC SYNDROME$2,845
M01 · FY2007 · RR · contact PI
SCCOR in Metabolic Syndrome and Vascular Disease$2,029,490
P50 · FY2006 · HL · contact PI
Genotoxic Stress, Atherosclerosis and Metabolic Syndrom$491,572
P50 · FY2006 · HL · contact PI
UNCOUPLING, AGING AND ATHEROSCLEROSIS$373,511
R01 · FY2006 · AG · contact PI
Animal Model Research Core C$170,940
P30 · FY2006 · DK · contact PI
MOUSE PHENOTYPING CORE$118,728
P60 · FY2006 · DK · contact PI
Administrative Core$66,503
P50 · FY2006 · HL · contact PI
CHLOROQUINE AND THE METABOLIC SYNDROME$18,326
M01 · FY2006 · RR · contact PI
INSULIN RESISTANCE AND GLUCOCORTICOIDS$7,497
M01 · FY2006 · RR · contact PI
UNCOUPLING, AGING AND ATHEROSCLEROSIS$382,500
R01 · FY2005 · AG
ATHEROSCLEROSIS, DIABETES AND LPL$308,000
R01 · FY2005 · HL
INSULIN RESISTANCE AND GLUCOCORTICOIDS$65,723
M01 · FY2005 · RR
CHLOROQUINE AND THE METABOLIC SYNDROME$12,323
M01 · FY2005 · RR
CHLOROQUINE AND THE METABOLIC SYNDROME$110
P41 · FY2005 · RR
MOUSE PHENOTYPING CORE$0
P60 · FY2005 · DK
UNCOUPLING, AGING AND ATHEROSCLEROSIS$382,500
R01 · FY2004 · AG
ATHEROSCLEROSIS, DIABETES AND LPL$308,000
R01 · FY2004 · HL
Insulin Resistance and Glucocorticoids$33,853
M01 · FY2004 · RR
MOUSE PHENOTYPING CORE$0
P60 · FY2004 · DK
UNCOUPLING, AGING AND ATHEROSCLEROSIS$382,500
R01 · FY2003 · AG
ATHEROSCLEROSIS, DIABETES AND LPL$308,000
R01 · FY2003 · HL
SARCOPENIA, TNF ALPHA AND LPL--EFFECTS OF AGING/EXERCISE$260,192
R01 · FY2003 · AG
CORE--MOUSE PHENOTYPING$0
P60 · FY2003 · DK
UNCOUPLING, AGING AND ATHEROSCLEROSIS$383,541
R01 · FY2002 · AG
ATHEROSCLEROSIS, DIABETES AND LPL$308,000
R01 · FY2002 · HL
SARCOPENIA, TNF ALPHA AND LPL--EFFECTS OF AGING/EXERCISE$252,956
R01 · FY2002 · AG
CORE--ANIMAL MODEL RESEARCH$0
P30 · FY2002 · DK
EFFECTS OF CATECHOLAMINES ON SKELETAL MUSCLE LIPOPROTEIN LIPASE AFTER EXERCISE$0
M01 · FY2002 · RR
SARCOPENIA, TNF AND LPL--EFFECTS OF AGING AND EXERCISE$0
M01 · FY2002 · RR
LEPTIN RESPONSE TO EXERCISE$0
M01 · FY2002 · RR
ATHEROSCLEROSIS, DIABETES AND LPL$276,117
R01 · FY2001 · HL
SARCOPENIA, TNF ALPHA AND LPL--EFFECTS OF AGING/EXERCISE$245,925
R01 · FY2001 · AG
INTERMEDIARY METABOLISM AND A NOVEL RNA BINDING PROTEIN$215,364
R01 · FY2001 · DK
CORE--ANIMAL MODEL RESEARCH$0
P30 · FY2001 · DK
SARCOPENIA, TNF AND LPL--EFFECTS OF AGING AND EXERCISE$0
M01 · FY2001 · RR
LEPTIN RESPONSE TO EXERCISE$0
M01 · FY2001 · RR
EFFECTS OF CATECHOLAMINES ON SKELETAL MUSCLE LIPOPROTEIN LIPASE AFTER EXERCISE$0
M01 · FY2001 · RR
ATHEROSCLEROSIS, DIABETES AND LPL$268,074
R01 · FY2000 · HL
SARCOPENIA, TNF ALPHA AND LPL--EFFECTS OF AGING/EXERCISE$239,103
R01 · FY2000 · AG
INTERMEDIARY METABOLISM AND A NOVEL RNA BINDING PROTEIN$209,146
R01 · FY2000 · DK
CORE--ANIMAL MODEL RESEARCH$190,000
P30 · FY2000 · DK
LEPTIN RESPONSE TO EXERCISE$0
M01 · FY2000 · RR
EFFECTS OF CATECHOLAMINES ON SKELETAL MUSCLE LIPOPROTEIN LIPASE AFTER EXERCISE$0
M01 · FY2000 · RR
SARCOPENIA, TNF AND LPL--EFFECTS OF AGING AND EXERCISE$0
M01 · FY2000 · RR